Physician profile
Alex Wang
NPI 1841815883
$676.30
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $250 · 2023: $262 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $210.46 | 2022-2023 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Nestle Healthcare Nutrition INC. | $122.85 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $40.07 | 2024 | Ajovy |
| Exact Sciences Corporation | $37.43 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $27.14 | 2024 | |
| Axogen | $24.80 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Bioventus LLC | $23.72 | 2024 | Durolane |
| Glaxosmithkline, LLC. | $17.96 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Hologic Sales and Service, LLC | $15.84 | 2023 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $15.68 | 2024 | Eohilia |
| Lilly USA, LLC | $15.35 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.